It is a pharma private limited company based in New Delhi, Delhi, India, established in 2001.
2001 | New Delhi, Delhi, India | ActiveCosmotec Medicaments Private Limited, a active private limited company, was established on 11 July 2001 in New Delhi, Delhi, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U51397DL2001PTC111620. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹9.00 M and a paid-up capital of ₹6.67 M.
It upholds a compliant status. Its leadership includes Rajesh Kumar Goyal (Director), Jitender Goyal Kumar (Director), Alka Goyal (Director). Past directors included Vishal Goyal, Jitender Goyal Kumar. It holds ₹7.57 M open charges and ₹4.50 M settled loans. Its latest AGM occurred on 27 September 2024, with the balance sheet filed on 31 March 2024. It is based at 2 First Floor Hr 8Balaji Complex Sharma Market, New Delhi, Delhi, 110044.
U51397DL2001PTC111620
111620
11 July 2001
₹9.00 M
₹6.67 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Cosmotec Medicaments Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rajesh Kumar Goyal | Director | 30 Jul 2001 | Current |
| Jitender Goyal Kumar | Director | 18 Jun 2016 | Current |
| Alka Goyal | Director | 11 Jul 2001 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 27 May 2021 | Past |
| Pramod Abcsdd | Director | 09 Oct 2015 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Cosmotec Medicaments Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 62.66% decrease. The company also saw a substantial fall in profitability, with a 33.03% decrease in profit. The company's net worth moved up by a moderate rise of 0.88%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Cosmotec Medicaments had a public holding of 64.33%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹7,570,000.00
₹4,500,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 26 Feb 2013 | Hdfc Bank Limited | ₹3.07 M | Open |
| 28 Jan 2010 | 3I Infotech Trusteeship Services Limited | ₹4.50 M | Open |
| 16 Jan 2010 | 3I Infotech Trusteeship Services Limited | ₹4.50 M | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Cosmotec Medicaments, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Cosmotec Medicaments, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cosmotec Medicaments's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Cosmotec Medicaments Private Limited last Annual general meeting of members was held on 27 Sep 2024 as per latest MCA records. was recorded as a recent event.
The activity Cosmotec Medicaments Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was completed.
The activity Jitender Goyal Kumar was appointed as a Director was appointed as a Director on 18 Jun 2016 & has been associated with this company since 9 years 6 months . was completed.
The activity A charge with Hdfc Bank Limited of Rs. 3.07 M registered on 26 Feb 2013 with Charge ID 10407428 was modified on 04 Nov 2015. was completed.
Progress on A charge with Hdfc Bank Limited amounted to Rs. 3.07 M with Charge ID 10407428 was registered on 26 Feb 2013. was documented.
The activity A charge registered on 16 Jan 2010 via Charge ID 10198064 with 3I Infotech Trusteeship Services Limited was fully satisfied on 13 Feb 2013. was completed.
The CIN of Cosmotec Medicaments Private Limited is U51397DL2001PTC111620.
Cosmotec Medicaments Private Limited is headquartered at 2 First Floor Hr 8Balaji Complex Sharma Market, New Delhi, Delhi, 110044.
Cosmotec Medicaments Private Limited was incorporated on 11 July 2001.
The current directors of Cosmotec Medicaments Private Limited are
The primary industry of Cosmotec Medicaments Private Limited is Trade.
Cosmotec Medicaments Private Limited is unlisted.
The authorized capital of Cosmotec Medicaments Private Limited is ₹9.00 M, and the paid-up capital is ₹6.67 M.
The compliance status of Cosmotec Medicaments Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX